[1] | Alzheimer’s Association. 2012 Alzheimer’s Disease Facts and Figures. Alzheimer’s & Dementia, vol.8, no.2, USA, 2012. |
[2] | Newport M. What if there was a cure for Alzheimer’s disease and no one knew? A case study.www.coconutketones.com/whatifcure.pdf. 2008 Jul 22. |
[3] | Moore EH. Doctor says an oil lessened Alzheimer's effects on her husband. Tampa Bay Times.www.tampabay.com/news/aging/article879333.ece. 2008 Oct 29. |
[4] | Villariba CC. Virgin coconut oil hailed as cure for Alzheimer’s. www.newsinfo.inquirer.net. 2011 Aug 28. |
[5] | Pope S. (Sarah, The Healthy Home Economist). Virgin coconut oil halts severe dementia in 35 days. The Philippine Inquirer.www.healthisinreach.blogspot.com/.../virgin-coconut-oil-hailed-as-alzheim... 2011 Sep 23. |
[6] | Jauregui J. Man in his 80s with “severe dementia” returning to old self after starting coconut oil. www.hawkeshealth.net/community/forumdisplay.php?f=103, 2012 Mar 28. |
[7] | Johnson L. Coconut oil touted as Alzheimer’s remedy. www.cbn.com/cbnnews/healthscience/2012/January/Coconut-oil-Touted..., 2012 Jan 5. |
[8] | Memory XL: Patented by University of Massachusetts, over-the-counter vitamin nutriceutical with folic acid 400 mg, Vitamin B12 6 micrograms, alpha-tocopherol/Vitamin E 30 IU, S-adenosyl methionine (SAM) 400 mg, N-acetyl cysteine (NAC) 600 mg, & amp; acetyl-L-carnitine (ALCAR) 500 mg; 2 pills daily for 12 months. Benefits of study did not appear to outweigh subject inconvenience, so study was stopped prematurely. www.clinicaltrials.gov/ct2/show/NCT00903695. |
[9] | Shilhavy B. The Low-fat diet and cholesterol lowering drugs part of the problem? www.healthimpactnews.com/.../coconut-oil-and-alzheimer’s-disease-the-ne... Health Impact News, 2012 Jan 12. |
[10] | Bergqvist AGC. Long-term monitoring of the ketogenic diet: Do's and don'ts. Epilepsy Res,doi:10.1016/j.eplepsyres.2011.05.020. PMID 21855296, 2011 Aug 18. |
[11] | Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev, 59(2), pp. 293–315. doi:10.1016/j.brainresrev.2008.09.002. PMID 18845187. 2009 Mar. |
[12] | Gasior M, Rogawski MA, Hartman AL. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol, vol.17, no.5-6, pp.431-9, 2006. |
[13] | Lemieux H, Bulteau AL, Friguet B, Tardif J, Blier PU. Dietary fatty acids and oxidative stress in the heart mitochondria. Mitochondrion,vol.11, no.1, pp.97-103, 2011. |
[14] | Nevin KG, Rajamohan T. Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation. Clin Biochem, vol.37, no.9, pp.830-5, 2004. |
[15] | Freeman LR, Haley-Zitlin V, Stevens C, Granholm AC. Diet-induced effects on neuronal and glial elements in the middle-aged rat hippocampus. Nutr Neurosc,vol.14, no.1, pp.32-44, 2011. |
[16] | Granholm AC, Bimonte-Nelson HA, Moore, AB, Nelson ME, Freeman LR, Sambamurti K. Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. J Alzheimers Dis, vol.14, no.2, pp.133–45, 2008. |
[17] | Wyatt CJ, Carballido SP, Mendez RO. Alpha- and gamma-tocopherol content of selected foods in the Mexican diet: Effect of cooking loss. J Agric Food Chem, 46, pp.4657-61, 1998. |
[18] | Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol, vol.12, pp.105–12, 2001. |
[19] | Laureles LR, Rodriguez FM, Reano CE, Santos GA, Laurena AC, Mendoza EM. Variability in fatty acid and triacylglycerol composition of the oil of coconut (Cocos nucifera L.) hybrids and their parentals. J Agric Food Chem, vol.50, no.6, pp.1581-6, 2002. |
[20] | Feranil AB, Duazo PL, Kuzawa CW, Adair LS. Coconut oil is associated with a beneficial lipid profile in pre-menopausal women in the Philippines. Asia Pac J Clin Nutr, vol.20, no.2, pp. 190-5, 2011. |
[21] | Liau KM, Lee YY, Chen CK, Rasool AH. An open-label pilot study to assess the efficacy and safety of virgin coconut oil in reducing visceral adiposity. ISRN Pharmacol, 949686, 2011. |
[22] | Krikorian R, Shidler MD, Dangelo K, Couch SC, Benoit SC, Clegg DJ. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging, vol.33, no.2, pp. 425.e19-27. Epub 2012. |
[23] | Henderson ST. Ketone bodies as a therapeutic for Alzheimer’s disease. Neurotherapeutics, vol.5, no.3, pp. 470-80, 2008. |
[24] | Kashiwaya Y,Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. D-b-Hydroxybutyrate protects neurons in models of Alzheimer’s and Parkinson’s disease. Proceedings of the National Academy of Sciences of the United States of America (PNAS), vol.97, no.10, pp.5440-4, 2000. |
[25] | Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging, vol.25, no.3, pp.311-4, 2004. |
[26] | Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: A Randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond), vol. 6, no.31, pp.1619-44, 2009. |
[27] | Taha AY, Henderson ST, Burnham WM. Dietary enrichment with medium chain triglycerides (AC-1203) elevates polyunsaturated fatty acids in the parietal cortex of aged dogs: Implications for treating age-related cognitive decline. Neurochem Res, vol.34, no.9, pp.1619-25, 2009. |
[28] | Aisen PS, Cummings J, Schneider LS. Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease. Cold Spring Harb Perspect Med, vol.2, no.3, a006395, 2012. |
[29] | Costantini LC, Barr LJ, Vogel JL, Henderson ST. Hypometabolism as a therapeutic target in Alzheimer's disease. BMC Neurosci, vol.9, Suppl 2, pp.S16, 2008 Dec 3. |
[30] | Costantini LC, Vogel JL, Barr LJ, Henderson ST. Clinical efficacy of AC-1202 (Ketasyn™) in mild to moderate Alzheimer’s disease. Paper presented at: 59th Annual Meeting of the American Academy of Neurology, "Late-Breaking Science" Session, Boston, MA, USA, 2007. |
[31] | Devere R. Ketones - A New treatment for Alzheimer's disease? Practical Neurology, pp. 14-16.www.practicalneurology.org/issues/0509/PN0509_07.php. |
[32] | Henderson ST, Poirier J. Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; A Randomized, double-blind, placebo-controlled study. BMC Med Gen, vol.12, no.137, doi: 10.1186/1471-2350-12-137, 2011. |
[33] | Barañano KW, Hartman AL. The Ketogenic diet: Uses in epilepsy and other neurologic illnesses. Curr Treat Options Neurol,vol.10, no.6, pp.410–9, 2008. |
[34] | Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: The Atherosclerosis Risk in Communities Study. Am J Clin Nutr, vol.85, no.4, pp.1103–11, 2007. |
[35] | Dullemeijer C, Durga J, Brouwer IA, van de Rest O, Kok FJ, Brummer RJ, et al. n 3 fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr, vol.86, no.5, pp.1479–85, 2007. |
[36] | Berger P. Axona, MCT & coconut oil: Differences & benefits. Alzheimer's Weekly,www.alzheimersweekly.com/.../axona-mct-coconut-oil-differences-benefits, 2012 Jan 31. |
[37] | Wattmo C, Wallin AK, Londos E, Minthon, L. Predictors of long-term cognitive outcome in Alzheimer's disease. Alzheimers Res Ther, vol.3, no.4, pp.23, 2011. |
[38] | Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis. Clin Interv Aging, vol.3, no.2, pp. 211-25, 2008. |
[39] | Ellis JM. Cholinesterase inhibitors in the treatment of dementia. J Am Osteopath Assoc, vol.105, no.3, pp.145-58, 2005. |
[40] | Schneider LS, Dagerman KS, Higgins JP, McShane R. Lack of evidence for the efficacy of memantine in mild Alzheimer disease. Arch Neurol, vol.68, no.8, pp.991-8, 2011. |
[41] | Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ; Memantine Study Group. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med, vol.348, no.14, pp. 1333-41, 2003. |
[42] | Nevin KG, Rajamohan T. Wet and dry extraction of coconut oil: Impact on lipid metabolic and antioxidant status in cholesterol coadministered rats. Can J Physiol Pharmacol, vol.87, no.8, pp. 610–6, 2009. |
[43] | Kurian PKV. Commercial Crops Technology: Horticulture Science Series. New India Publishing, vol.8, pp. 202–6. ISBN 8189422529; www.coconutoil.com, 2007. |
[44] | Axona Information from Drugs.com. Axona. www.drugs.com/drp.axona.html. |
[45] | Keto-dementia Diet, Article #2.www.centerwatch.com/drug-information/fda-. |